A Comparative Study of Sleep Parameters in Adult Survivors of Childhood Acute Lymphoblastic Leukemia and Healthy Peers: Insights from Accelerometer Data

Table 4

Overview of meeting recommendations for sleep and sleep efficiency.

	ALS		CG		Difference
	N	%	N	%	value
Sleep >420 min/day
Male	1	9	1	13	0.55
Female	2	22	3	23	0.96
Total	3	15	4	19	0.74
Sleep efficiency >85%
Male	9	82	7	100	0.25
Female	7	78	9	69	0.65
Total	16	80	16	80	1.00

N, number of participants; ALS, adult survivors of childhood acute lymphoblastic leukemia; CG, control group.